The Metabolic Pattern of Idiopathic REM Sleep Behavior Disorder Reflects Early-Stage Parkinson Disease
Idiopathic REM sleep behavior disorder (iRBD) is considered a prodromal stage of Parkinson disease (PD) and other Lewy body disorders. Spatial covariance analysis of F-FDG PET data has disclosed a specific brain pattern of altered glucose metabolism in PD. In this study, we identify the metabolic pa...
Saved in:
| Published in | Journal of Nuclear Medicine Vol. 59; no. 9; pp. 1437 - 1444 |
|---|---|
| Main Authors | , , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
United States
Society of Nuclear Medicine
01.09.2018
|
| Subjects | |
| Online Access | Get full text |
| ISSN | 0161-5505 1535-5667 2159-662X 2159-662X 1535-5667 |
| DOI | 10.2967/jnumed.117.202242 |
Cover
| Abstract | Idiopathic REM sleep behavior disorder (iRBD) is considered a prodromal stage of Parkinson disease (PD) and other Lewy body disorders. Spatial covariance analysis of
F-FDG PET data has disclosed a specific brain pattern of altered glucose metabolism in PD. In this study, we identify the metabolic pattern underlying iRBD and compare it with the known PD pattern. To understand the relevance of the iRBD pattern to disease progression, we studied the expression of the iRBD pattern in de novo PD patients.
The iRBD-related pattern was identified in
F-FDG PET scans of 21 patients with polysomnographically confirmed iRBD and 19 controls using spatial covariance analysis. Expression of the iRBD-related pattern was subsequently computed in
F-FDG PET scans of 44 controls and 38 de novo, treatment-naïve PD patients. Of these 38 PD patients, 24 had probable REM sleep behavior disorder (RBD) according to the Mayo Sleep Questionnaire. Neuropsychologic evaluation showed mild cognitive impairment in 20 PD patients (PD-MCI), of whom 16 also had concomitant RBD and roughly half (11/20) had bilateral motor symptoms.
The iRBD-related pattern was characterized by relative hypermetabolism in the cerebellum, brain stem, thalamus, sensorimotor cortex, and hippocampus, and by relative hypometabolism in the middle cingulate, temporal, occipital, and parietal cortices. This topography partially overlapped with the PD-related pattern (PDRP). The iRBD-related pattern was significantly expressed in PD patients compared with controls (
< 0.0001). iRBD-related pattern expression was not significantly different between PD patients with and without probable RBD, or between PD patients with unilateral or bilateral parkinsonism. iRBD-related pattern (iRBDRP) expression was higher in PD-MCI patients than in PD patients with preserved cognition (
= 0.001). Subject scores on the iRBD-related pattern were highly correlated to subject scores on the PDRP (
= 0.94,
< 0.0001).
Our results show that the iRBDRP is an early manifestation of the PDRP. Expression of both PDRP and iRBDRP was higher in patients with a more severe form of PD (PD-MCI), which indicates that expression of the 2 patterns increases with disease severity. |
|---|---|
| AbstractList | Idiopathic REM sleep behavior disorder (iRBD) is considered a prodromal stage of Parkinson disease (PD) and other Lewy body disorders. Spatial covariance analysis of
F-FDG PET data has disclosed a specific brain pattern of altered glucose metabolism in PD. In this study, we identify the metabolic pattern underlying iRBD and compare it with the known PD pattern. To understand the relevance of the iRBD pattern to disease progression, we studied the expression of the iRBD pattern in de novo PD patients.
The iRBD-related pattern was identified in
F-FDG PET scans of 21 patients with polysomnographically confirmed iRBD and 19 controls using spatial covariance analysis. Expression of the iRBD-related pattern was subsequently computed in
F-FDG PET scans of 44 controls and 38 de novo, treatment-naïve PD patients. Of these 38 PD patients, 24 had probable REM sleep behavior disorder (RBD) according to the Mayo Sleep Questionnaire. Neuropsychologic evaluation showed mild cognitive impairment in 20 PD patients (PD-MCI), of whom 16 also had concomitant RBD and roughly half (11/20) had bilateral motor symptoms.
The iRBD-related pattern was characterized by relative hypermetabolism in the cerebellum, brain stem, thalamus, sensorimotor cortex, and hippocampus, and by relative hypometabolism in the middle cingulate, temporal, occipital, and parietal cortices. This topography partially overlapped with the PD-related pattern (PDRP). The iRBD-related pattern was significantly expressed in PD patients compared with controls (
< 0.0001). iRBD-related pattern expression was not significantly different between PD patients with and without probable RBD, or between PD patients with unilateral or bilateral parkinsonism. iRBD-related pattern (iRBDRP) expression was higher in PD-MCI patients than in PD patients with preserved cognition (
= 0.001). Subject scores on the iRBD-related pattern were highly correlated to subject scores on the PDRP (
= 0.94,
< 0.0001).
Our results show that the iRBDRP is an early manifestation of the PDRP. Expression of both PDRP and iRBDRP was higher in patients with a more severe form of PD (PD-MCI), which indicates that expression of the 2 patterns increases with disease severity. Idiopathic REM sleep behavior disorder (iRBD) is considered a prodromal stage of Parkinson disease (PD) and other Lewy body disorders. Spatial covariance analysis of 18F-FDG PET data has disclosed a specific brain pattern of altered glucose metabolism in PD. In this study, we identify the metabolic pattern underlying iRBD and compare it with the known PD pattern. To understand the relevance of the iRBD pattern to disease progression, we studied the expression of the iRBD pattern in de novo PD patients. Methods: The iRBD-related pattern was identified in 18F-FDG PET scans of 21 patients with polysomnographically confirmed iRBD and 19 controls using spatial covariance analysis. Expression of the iRBD-related pattern was subsequently computed in 18F-FDG PET scans of 44 controls and 38 de novo, treatment-naïve PD patients. Of these 38 PD patients, 24 had probable REM sleep behavior disorder (RBD) according to the Mayo Sleep Questionnaire. Neuropsychologic evaluation showed mild cognitive impairment in 20 PD patients (PD-MCI), of whom 16 also had concomitant RBD and roughly half (11/20) had bilateral motor symptoms. Results: The iRBD-related pattern was characterized by relative hypermetabolism in the cerebellum, brain stem, thalamus, sensorimotor cortex, and hippocampus, and by relative hypometabolism in the middle cingulate, temporal, occipital, and parietal cortices. This topography partially overlapped with the PD-related pattern (PDRP). The iRBD-related pattern was significantly expressed in PD patients compared with controls (P < 0.0001). iRBD-related pattern expression was not significantly different between PD patients with and without probable RBD, or between PD patients with unilateral or bilateral parkinsonism. iRBD-related pattern (iRBDRP) expression was higher in PD-MCI patients than in PD patients with preserved cognition (P = 0.001). Subject scores on the iRBD-related pattern were highly correlated to subject scores on the PDRP (r = 0.94, P < 0.0001). Conclusion: Our results show that the iRBDRP is an early manifestation of the PDRP. Expression of both PDRP and iRBDRP was higher in patients with a more severe form of PD (PD-MCI), which indicates that expression of the 2 patterns increases with disease severity.Idiopathic REM sleep behavior disorder (iRBD) is considered a prodromal stage of Parkinson disease (PD) and other Lewy body disorders. Spatial covariance analysis of 18F-FDG PET data has disclosed a specific brain pattern of altered glucose metabolism in PD. In this study, we identify the metabolic pattern underlying iRBD and compare it with the known PD pattern. To understand the relevance of the iRBD pattern to disease progression, we studied the expression of the iRBD pattern in de novo PD patients. Methods: The iRBD-related pattern was identified in 18F-FDG PET scans of 21 patients with polysomnographically confirmed iRBD and 19 controls using spatial covariance analysis. Expression of the iRBD-related pattern was subsequently computed in 18F-FDG PET scans of 44 controls and 38 de novo, treatment-naïve PD patients. Of these 38 PD patients, 24 had probable REM sleep behavior disorder (RBD) according to the Mayo Sleep Questionnaire. Neuropsychologic evaluation showed mild cognitive impairment in 20 PD patients (PD-MCI), of whom 16 also had concomitant RBD and roughly half (11/20) had bilateral motor symptoms. Results: The iRBD-related pattern was characterized by relative hypermetabolism in the cerebellum, brain stem, thalamus, sensorimotor cortex, and hippocampus, and by relative hypometabolism in the middle cingulate, temporal, occipital, and parietal cortices. This topography partially overlapped with the PD-related pattern (PDRP). The iRBD-related pattern was significantly expressed in PD patients compared with controls (P < 0.0001). iRBD-related pattern expression was not significantly different between PD patients with and without probable RBD, or between PD patients with unilateral or bilateral parkinsonism. iRBD-related pattern (iRBDRP) expression was higher in PD-MCI patients than in PD patients with preserved cognition (P = 0.001). Subject scores on the iRBD-related pattern were highly correlated to subject scores on the PDRP (r = 0.94, P < 0.0001). Conclusion: Our results show that the iRBDRP is an early manifestation of the PDRP. Expression of both PDRP and iRBDRP was higher in patients with a more severe form of PD (PD-MCI), which indicates that expression of the 2 patterns increases with disease severity. Idiopathic REM sleep behavior disorder (iRBD) is considered a prodromal stage of Parkinson disease (PD) and other Lewy body disorders. Spatial covariance analysis of 18F-FDG PET data has disclosed a specific brain pattern of altered glucose metabolism in PD. In this study, we identify the metabolic pattern underlying iRBD and compare it with the known PD pattern. To understand the relevance of the iRBD pattern to disease progression, we studied the expression of the iRBD pattern in de novo PD patients. Methods: The iRBD-related pattern was identified in 18F-FDG PET scans of 21 patients with polysomnographically confirmed iRBD and 19 controls using spatial covariance analysis. Expression of the iRBD-related pattern was subsequently computed in 18F-FDG PET scans of 44 controls and 38 de novo, treatment-naïve PD patients. Of these 38 PD patients, 24 had probable REM sleep behavior disorder (RBD) according to the Mayo Sleep Questionnaire. Neuropsychologic evaluation showed mild cognitive impairment in 20 PD patients (PD-MCI), of whom 16 also had concomitant RBD and roughly half (11/20) had bilateral motor symptoms. Results: The iRBD-related pattern was characterized by relative hypermetabolism in the cerebellum, brain stem, thalamus, sensorimotor cortex, and hippocampus, and by relative hypometabolism in the middle cingulate, temporal, occipital, and parietal cortices. This topography partially overlapped with the PD-related pattern (PDRP). The iRBD-related pattern was significantly expressed in PD patients compared with controls (P < 0.0001). iRBD-related pattern expression was not significantly different between PD patients with and without probable RBD, or between PD patients with unilateral or bilateral parkinsonism. iRBD-related pattern (iRBDRP) expression was higher in PD-MCI patients than in PD patients with preserved cognition (P = 0.001). Subject scores on the iRBD-related pattern were highly correlated to subject scores on the PDRP (r = 0.94, P < 0.0001). Conclusion: Our results show that the iRBDRP is an early manifestation of the PDRP. Expression of both PDRP and iRBDRP was higher in patients with a more severe form of PD (PD-MCI), which indicates that expression of the 2 patterns increases with disease severity. |
| Author | Janzen, Annette Pagani, Marco Mayer, Geert Renken, Remco J. Vadasz, David Oertel, Wolfgang H. Meles, Sanne K. Morbelli, Silvia Nobili, Flavio Leenders, Klaus L. Arnaldi, Dario |
| Author_xml | – sequence: 1 givenname: Sanne K. surname: Meles fullname: Meles, Sanne K. – sequence: 2 givenname: Remco J. surname: Renken fullname: Renken, Remco J. – sequence: 3 givenname: Annette surname: Janzen fullname: Janzen, Annette – sequence: 4 givenname: David surname: Vadasz fullname: Vadasz, David – sequence: 5 givenname: Marco surname: Pagani fullname: Pagani, Marco – sequence: 6 givenname: Dario surname: Arnaldi fullname: Arnaldi, Dario – sequence: 7 givenname: Silvia surname: Morbelli fullname: Morbelli, Silvia – sequence: 8 givenname: Flavio surname: Nobili fullname: Nobili, Flavio – sequence: 9 givenname: Geert surname: Mayer fullname: Mayer, Geert – sequence: 10 givenname: Klaus L. surname: Leenders fullname: Leenders, Klaus L. – sequence: 11 givenname: Wolfgang H. surname: Oertel fullname: Oertel, Wolfgang H. |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/29476004$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNkE1v1DAQhi1URLdLfwAXFIlLL1lsJ7HjI5QtVGoFaovUWzRxJqwXrx1sp9X-e7JKe-kBcRpp9Lzz8ZyQI-cdEvKO0RVXQn7cunGH3YoxueKU85K_IgvOKpULwe-PyIIywfKqotUxOYlxSykVdV2_IcdclVJQWi5If7fB7BoTtN4anf2AlDC4zPfZZWf8AGkzdW_W19mtRRyyz7iBB-ND9sVEHzoM2Q32FnWK2RqC3ee3CX7hNCb8Ni56d-AQIr4lr3uwEU-f6pL8vFjfnX_Lr75_vTz_dJXrQvKUV4KpFnrZM9YpLtpO1KqsQTLZaQpYtLxQqip5X4sOZCEKAOgRqVal4J3UxZLwee7oBtg_grXNEMwOwr5htDlIa2ZpzSStmaVNobM5NAT_Z8SYmp2JGq0Fh36ME0alqrma9i3Jhxfo1o_BTS81nHFRiYLxeqLeP1Fje9j1fMKz9glgM6CDjzFg_19XyhcZbRIk410KYOw_kn8BCVaoZA |
| CitedBy_id | crossref_primary_10_3233_JPD_181468 crossref_primary_10_1002_mds_30126 crossref_primary_10_1186_s40035_023_00356_y crossref_primary_10_1016_j_dadm_2019_04_002 crossref_primary_10_1038_s41531_024_00813_z crossref_primary_10_1159_000533297 crossref_primary_10_1007_s10072_019_04118_5 crossref_primary_10_1002_mds_27823 crossref_primary_10_1002_jnr_70029 crossref_primary_10_1007_s10072_023_06829_2 crossref_primary_10_1111_acer_14158 crossref_primary_10_3390_brainsci12091248 crossref_primary_10_3389_fneur_2019_01204 crossref_primary_10_1186_s10020_021_00327_x crossref_primary_10_1007_s00415_020_10271_1 crossref_primary_10_1016_j_sleep_2020_01_010 crossref_primary_10_1080_13803395_2019_1623180 crossref_primary_10_1515_revneuro_2018_0061 crossref_primary_10_1016_j_sleep_2024_06_024 crossref_primary_10_1111_ene_14215 crossref_primary_10_1002_mds_28592 crossref_primary_10_1038_s41531_024_00685_3 crossref_primary_10_1111_jsr_13880 crossref_primary_10_1212_WNL_0000000000210077 crossref_primary_10_1177_0271678X19828916 crossref_primary_10_3389_fneur_2020_563624 crossref_primary_10_1038_s41531_023_00557_2 crossref_primary_10_3389_fneur_2022_1009907 crossref_primary_10_1007_s00702_019_02001_3 crossref_primary_10_1007_s13311_020_00994_4 crossref_primary_10_1093_braincomms_fcad021 crossref_primary_10_3389_fnins_2022_930735 crossref_primary_10_1002_mds_29236 crossref_primary_10_1007_s00259_023_06289_y crossref_primary_10_1093_sleep_zsae052 crossref_primary_10_1016_j_sleep_2024_12_003 crossref_primary_10_1007_s11682_021_00615_4 crossref_primary_10_1038_s41467_024_54695_z crossref_primary_10_1080_14737175_2019_1640603 crossref_primary_10_1093_sleep_zsaa199 crossref_primary_10_3233_JPD_230385 crossref_primary_10_1007_s00702_024_02846_3 crossref_primary_10_1016_j_nicl_2020_102294 crossref_primary_10_1016_j_ynirp_2021_100026 crossref_primary_10_3390_brainsci11040433 crossref_primary_10_3988_jcn_2019_15_2_175 crossref_primary_10_1212_WNL_0000000000210105 crossref_primary_10_1002_mds_28859 crossref_primary_10_1016_j_parkreldis_2019_03_017 crossref_primary_10_1007_s11910_022_01171_0 crossref_primary_10_1002_mds_29188 crossref_primary_10_1212_WNL_0000000000208015 crossref_primary_10_1142_S0129065719500102 crossref_primary_10_1002_mds_27960 crossref_primary_10_2967_jnumed_124_268754 crossref_primary_10_1007_s00259_021_05205_6 crossref_primary_10_1093_sleep_zsae308 crossref_primary_10_1016_S1474_4422_18_30169_8 crossref_primary_10_1016_S1474_4422_21_00030_2 crossref_primary_10_1016_S1474_4422_21_00176_9 crossref_primary_10_1093_sleep_zsab232 crossref_primary_10_3390_jpm11090880 crossref_primary_10_1007_s41105_024_00568_3 crossref_primary_10_3233_JAD_220653 crossref_primary_10_1007_s11065_022_09572_1 crossref_primary_10_1016_j_nicl_2023_103475 crossref_primary_10_3233_JPD_202117 crossref_primary_10_1038_s41531_024_00800_4 crossref_primary_10_1038_s41531_023_00532_x crossref_primary_10_7759_cureus_17026 crossref_primary_10_1016_j_sleep_2024_03_012 crossref_primary_10_1002_mds_29012 crossref_primary_10_1002_mds_29177 crossref_primary_10_1016_j_parkreldis_2021_07_022 crossref_primary_10_1002_mds_29138 crossref_primary_10_1038_s41582_022_00753_3 |
| Cites_doi | 10.1016/j.neuroimage.2009.06.012 10.1212/01.wnl.0000242879.39415.49 10.1016/S1474-4422(11)70152-1 10.1002/mds.25361 10.1002/mds.27094 10.1016/j.neuroimage.2008.01.056 10.3233/JPD-150583 10.1007/s11910-017-0738-x 10.1523/JNEUROSCI.4188-09.2010 10.1007/s00259-012-2198-5 10.1002/ana.23631 10.1016/j.tins.2009.06.003 10.1212/WNL.0000000000000130 10.1016/j.nicl.2014.06.007 10.1016/S1474-4422(13)70054-1 10.1212/WNL.0b013e3182886a76 10.1016/S1474-4422(13)70056-5 10.1212/WNL.0b013e318278b658 10.1073/pnas.1411011112 10.1212/01.wnl.0000340980.19702.6e 10.2967/jnumed.111.089946 10.1002/mds.23721 10.1038/srep40779 10.1002/mds.26424 10.1016/j.parkreldis.2013.02.013 10.1038/sj.jcbfm.9600358 10.1002/ana.24385 10.1016/j.sleep.2012.10.009 10.1073/pnas.1206247109 10.1007/s12021-014-9235-4 10.1016/S0197-4580(02)00065-9 10.1016/j.tins.2014.02.009 10.1016/j.neuroimage.2010.10.025 10.1038/jcbfm.1994.99 10.1016/j.parkreldis.2016.05.031 10.3389/fnsys.2011.00031 10.1109/TAC.1974.1100705 10.1093/brain/awn075 10.1002/mds.26431 10.1016/j.sleep.2010.12.009 10.1093/brain/aws093 10.1371/journal.pone.0089741 10.1093/brain/awu290 10.1212/WNL.0b013e3182315259 10.1007/s00221-013-3621-2 10.1016/S1474-4422(10)70216-7 10.1007/s00415-011-6149-z 10.1038/jcbfm.2015.173 |
| ContentType | Journal Article |
| Contributor | Timmermann, Lars Adriaanse, Sofie M Kesper, Karl Girtler, Nicola Depboylu, Candan Sambuceti, Gianmario Reetz, Kathrin Luster, Marcus Booij, Jan Reesink, Fransje E Sittig-Wiegand, Elisabeth Overeem, Sebastiaan Höffken, Helmut Pijpers, Angelique van Laar, Teus Teune, Laura K Jonsson, Cathrine |
| Contributor_xml | – sequence: 1 givenname: Elisabeth surname: Sittig-Wiegand fullname: Sittig-Wiegand, Elisabeth – sequence: 2 givenname: Candan surname: Depboylu fullname: Depboylu, Candan – sequence: 3 givenname: Kathrin surname: Reetz fullname: Reetz, Kathrin – sequence: 4 givenname: Sebastiaan surname: Overeem fullname: Overeem, Sebastiaan – sequence: 5 givenname: Angelique surname: Pijpers fullname: Pijpers, Angelique – sequence: 6 givenname: Fransje E surname: Reesink fullname: Reesink, Fransje E – sequence: 7 givenname: Teus surname: van Laar fullname: van Laar, Teus – sequence: 8 givenname: Laura K surname: Teune fullname: Teune, Laura K – sequence: 9 givenname: Helmut surname: Höffken fullname: Höffken, Helmut – sequence: 10 givenname: Marcus surname: Luster fullname: Luster, Marcus – sequence: 11 givenname: Lars surname: Timmermann fullname: Timmermann, Lars – sequence: 12 givenname: Karl surname: Kesper fullname: Kesper, Karl – sequence: 13 givenname: Sofie M surname: Adriaanse fullname: Adriaanse, Sofie M – sequence: 14 givenname: Jan surname: Booij fullname: Booij, Jan – sequence: 15 givenname: Gianmario surname: Sambuceti fullname: Sambuceti, Gianmario – sequence: 16 givenname: Nicola surname: Girtler fullname: Girtler, Nicola – sequence: 17 givenname: Cathrine surname: Jonsson fullname: Jonsson, Cathrine |
| Copyright | 2018 by the Society of Nuclear Medicine and Molecular Imaging. Copyright Society of Nuclear Medicine Sep 1, 2018 |
| Copyright_xml | – notice: 2018 by the Society of Nuclear Medicine and Molecular Imaging. – notice: Copyright Society of Nuclear Medicine Sep 1, 2018 |
| CorporateAuthor | the REMPET Study Group REMPET Study Group |
| CorporateAuthor_xml | – name: the REMPET Study Group – name: REMPET Study Group |
| DBID | AAYXX CITATION NPM 4T- 8FD FR3 K9. M7Z NAPCQ P64 7X8 ADTOC UNPAY |
| DOI | 10.2967/jnumed.117.202242 |
| DatabaseName | CrossRef PubMed Docstoc Technology Research Database Engineering Research Database ProQuest Health & Medical Complete (Alumni) Biochemistry Abstracts 1 Nursing & Allied Health Premium Biotechnology and BioEngineering Abstracts MEDLINE - Academic Unpaywall for CDI: Periodical Content Unpaywall |
| DatabaseTitle | CrossRef PubMed Nursing & Allied Health Premium Technology Research Database Docstoc Biochemistry Abstracts 1 ProQuest Health & Medical Complete (Alumni) Engineering Research Database Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
| DatabaseTitleList | PubMed MEDLINE - Academic Nursing & Allied Health Premium |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: UNPAY name: Unpaywall url: https://proxy.k.utb.cz/login?url=https://unpaywall.org/ sourceTypes: Open Access Repository |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 2159-662X 1535-5667 |
| EndPage | 1444 |
| ExternalDocumentID | 10.2967/jnumed.117.202242 29476004 10_2967_jnumed_117_202242 |
| Genre | Research Support, Non-U.S. Gov't Journal Article |
| GroupedDBID | 123 18M 41~ 5VS 96U AAYXX ACGFO AEGXH AIAGR ALMA_UNASSIGNED_HOLDINGS CITATION GX1 N9A RHI TSM U5U W8F --- -~X .55 .GJ 29L 2WC 3O- 53G 5RE 7RV 7X7 88E 88I 8AF 8AO 8FE 8FG 8FH 8FI 8FJ 8R4 8R5 8WZ A6W ABEFU ABSQV ABUWG ACGOD ACIWK ACPRK ADDZX ADMOG AENEX AFFNX AFKRA AFOSN AFRAH AHMBA AI. ALIPV ARAPS AZQEC BBNVY BENPR BGLVJ BHPHI BKEYQ BPHCQ BVXVI CCPQU CS3 DIK DU5 DWQXO E3Z EBD EBS EJD EMOBN EX3 F5P F9R FYUFA GNUQQ H13 HCIFZ HMCUK I-F IL9 INIJC J5H KQ8 L7B LK8 M1P M2P M2Q M7P N4W NAPCQ NPM OK1 P2P P62 PHGZM PHGZT PJZUB PPXIY PQGLB PQQKQ PROAC PSQYO Q2X R0Z RNS RWL S0X SJN SV3 TAE TR2 TUS UKHRP VH1 WH7 WOQ WOW X7M YHG YQJ ZGI ZXP 4T- 8FD FR3 K9. M7Z P64 7X8 ADTOC UNPAY |
| ID | FETCH-LOGICAL-c372t-5619baf7f11d926bd68948a717dc0ae3b2399542f86da7363aaafee0c9462d7c3 |
| IEDL.DBID | UNPAY |
| ISSN | 0161-5505 1535-5667 2159-662X |
| IngestDate | Sun Oct 26 03:31:21 EDT 2025 Thu Oct 02 08:34:42 EDT 2025 Mon Oct 06 18:24:31 EDT 2025 Mon Jul 21 05:58:14 EDT 2025 Tue Jul 01 01:45:19 EDT 2025 Thu Apr 24 23:12:23 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 9 |
| Keywords | Neurology metabolic pattern statistical 18F-FDG-PET idiopathic REM PET/CT α-synucleinopathy Parkinson’s disease related pattern sleep behavior disorder analysis |
| Language | English |
| License | 2018 by the Society of Nuclear Medicine and Molecular Imaging. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c372t-5619baf7f11d926bd68948a717dc0ae3b2399542f86da7363aaafee0c9462d7c3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| OpenAccessLink | https://proxy.k.utb.cz/login?url=http://jnm.snmjournals.org/content/59/9/1437.full.pdf |
| PMID | 29476004 |
| PQID | 2126563128 |
| PQPubID | 40808 |
| PageCount | 8 |
| ParticipantIDs | unpaywall_primary_10_2967_jnumed_117_202242 proquest_miscellaneous_2007982936 proquest_journals_2126563128 pubmed_primary_29476004 crossref_primary_10_2967_jnumed_117_202242 crossref_citationtrail_10_2967_jnumed_117_202242 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2018-09-00 20180901 |
| PublicationDateYYYYMMDD | 2018-09-01 |
| PublicationDate_xml | – month: 09 year: 2018 text: 2018-09-00 |
| PublicationDecade | 2010 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States – name: New York |
| PublicationTitle | Journal of Nuclear Medicine |
| PublicationTitleAlternate | J Nucl Med |
| PublicationYear | 2018 |
| Publisher | Society of Nuclear Medicine |
| Publisher_xml | – name: Society of Nuclear Medicine |
| References | Meles (2021051712122534000_59.9.1437.21) 2017; 32 2021051712122534000_59.9.1437.30 2021051712122534000_59.9.1437.31 2021051712122534000_59.9.1437.12 2021051712122534000_59.9.1437.34 2021051712122534000_59.9.1437.13 2021051712122534000_59.9.1437.35 2021051712122534000_59.9.1437.10 Zhu (2021051712122534000_59.9.1437.28) 2017; 7 2021051712122534000_59.9.1437.32 2021051712122534000_59.9.1437.11 2021051712122534000_59.9.1437.33 2021051712122534000_59.9.1437.17 2021051712122534000_59.9.1437.39 2021051712122534000_59.9.1437.14 2021051712122534000_59.9.1437.36 2021051712122534000_59.9.1437.15 2021051712122534000_59.9.1437.37 2021051712122534000_59.9.1437.18 Delaville (2021051712122534000_59.9.1437.38) 2011; 5 2021051712122534000_59.9.1437.19 Boeve (2021051712122534000_59.9.1437.7) 2013; 12 2021051712122534000_59.9.1437.9 2021051712122534000_59.9.1437.8 Fereshtehnejad (2021051712122534000_59.9.1437.22) 2017; 17 2021051712122534000_59.9.1437.6 2021051712122534000_59.9.1437.5 Arnaldi (2021051712122534000_59.9.1437.23) 2016; 29 2021051712122534000_59.9.1437.41 Teune (2021051712122534000_59.9.1437.16) 2014; 5 2021051712122534000_59.9.1437.20 2021051712122534000_59.9.1437.42 2021051712122534000_59.9.1437.40 2021051712122534000_59.9.1437.45 2021051712122534000_59.9.1437.24 2021051712122534000_59.9.1437.46 2021051712122534000_59.9.1437.43 2021051712122534000_59.9.1437.44 2021051712122534000_59.9.1437.4 2021051712122534000_59.9.1437.27 2021051712122534000_59.9.1437.3 2021051712122534000_59.9.1437.2 2021051712122534000_59.9.1437.25 2021051712122534000_59.9.1437.47 2021051712122534000_59.9.1437.1 2021051712122534000_59.9.1437.26 2021051712122534000_59.9.1437.48 2021051712122534000_59.9.1437.29 |
| References_xml | – ident: 2021051712122534000_59.9.1437.34 doi: 10.1016/j.neuroimage.2009.06.012 – ident: 2021051712122534000_59.9.1437.41 doi: 10.1212/01.wnl.0000242879.39415.49 – ident: 2021051712122534000_59.9.1437.31 doi: 10.1016/S1474-4422(11)70152-1 – ident: 2021051712122534000_59.9.1437.17 doi: 10.1002/mds.25361 – volume: 32 start-page: 1482 year: 2017 ident: 2021051712122534000_59.9.1437.21 article-title: FDG PET, dopamine transporter SPECT, and olfaction: combining biomarkers in REM sleep behavior disorder publication-title: Mov Disord. doi: 10.1002/mds.27094 – ident: 2021051712122534000_59.9.1437.27 doi: 10.1016/j.neuroimage.2008.01.056 – ident: 2021051712122534000_59.9.1437.45 doi: 10.3233/JPD-150583 – volume: 17 start-page: 34 year: 2017 ident: 2021051712122534000_59.9.1437.22 article-title: Subtypes of parkinson's disease: what do they tell us about disease progression? publication-title: Curr Neurol Neurosci Rep. doi: 10.1007/s11910-017-0738-x – ident: 2021051712122534000_59.9.1437.29 doi: 10.1523/JNEUROSCI.4188-09.2010 – ident: 2021051712122534000_59.9.1437.47 doi: 10.1007/s00259-012-2198-5 – ident: 2021051712122534000_59.9.1437.15 doi: 10.1002/ana.23631 – ident: 2021051712122534000_59.9.1437.11 doi: 10.1016/j.tins.2009.06.003 – ident: 2021051712122534000_59.9.1437.19 doi: 10.1212/WNL.0000000000000130 – volume: 5 start-page: 240 year: 2014 ident: 2021051712122534000_59.9.1437.16 article-title: Parkinson’s disease-related perfusion and glucose metabolic brain patterns identified with PCASL-MRI and FDG-PET imaging publication-title: Neuroimage Clin. doi: 10.1016/j.nicl.2014.06.007 – volume: 12 start-page: 469 year: 2013 ident: 2021051712122534000_59.9.1437.7 article-title: Idiopathic REM sleep behaviour disorder in the development of Parkinson’s disease publication-title: Lancet Neurol. doi: 10.1016/S1474-4422(13)70054-1 – ident: 2021051712122534000_59.9.1437.37 doi: 10.1212/WNL.0b013e3182886a76 – ident: 2021051712122534000_59.9.1437.3 doi: 10.1016/S1474-4422(13)70056-5 – ident: 2021051712122534000_59.9.1437.40 doi: 10.1212/WNL.0b013e318278b658 – ident: 2021051712122534000_59.9.1437.48 doi: 10.1073/pnas.1411011112 – ident: 2021051712122534000_59.9.1437.1 doi: 10.1212/01.wnl.0000340980.19702.6e – ident: 2021051712122534000_59.9.1437.44 doi: 10.2967/jnumed.111.089946 – ident: 2021051712122534000_59.9.1437.42 doi: 10.1002/mds.23721 – volume: 7 start-page: 40779 year: 2017 ident: 2021051712122534000_59.9.1437.28 article-title: Clinical variations in Parkinson’s disease patients with or without REM sleep behaviour disorder: a meta-analysis publication-title: Sci Rep. doi: 10.1038/srep40779 – ident: 2021051712122534000_59.9.1437.10 doi: 10.1002/mds.26424 – ident: 2021051712122534000_59.9.1437.18 doi: 10.1016/j.parkreldis.2013.02.013 – ident: 2021051712122534000_59.9.1437.14 doi: 10.1038/sj.jcbfm.9600358 – ident: 2021051712122534000_59.9.1437.6 doi: 10.1002/ana.24385 – ident: 2021051712122534000_59.9.1437.4 doi: 10.1016/j.sleep.2012.10.009 – ident: 2021051712122534000_59.9.1437.33 doi: 10.1073/pnas.1206247109 – ident: 2021051712122534000_59.9.1437.25 doi: 10.1007/s12021-014-9235-4 – ident: 2021051712122534000_59.9.1437.8 doi: 10.1016/S0197-4580(02)00065-9 – ident: 2021051712122534000_59.9.1437.32 doi: 10.1016/j.tins.2014.02.009 – ident: 2021051712122534000_59.9.1437.12 doi: 10.1016/j.neuroimage.2010.10.025 – ident: 2021051712122534000_59.9.1437.13 doi: 10.1038/jcbfm.1994.99 – volume: 29 start-page: 47 year: 2016 ident: 2021051712122534000_59.9.1437.23 article-title: Functional neuroimaging and clinical features of drug naive patients with de novo Parkinson’s disease and probable RBD publication-title: Parkinsonism Relat Disord. doi: 10.1016/j.parkreldis.2016.05.031 – volume: 5 start-page: 31 year: 2011 ident: 2021051712122534000_59.9.1437.38 article-title: Noradrenaline and Parkinson’s disease publication-title: Front Syst Neurosci. doi: 10.3389/fnsys.2011.00031 – ident: 2021051712122534000_59.9.1437.26 doi: 10.1109/TAC.1974.1100705 – ident: 2021051712122534000_59.9.1437.35 doi: 10.1093/brain/awn075 – ident: 2021051712122534000_59.9.1437.9 doi: 10.1002/mds.26431 – ident: 2021051712122534000_59.9.1437.24 doi: 10.1016/j.sleep.2010.12.009 – ident: 2021051712122534000_59.9.1437.2 doi: 10.1093/brain/aws093 – ident: 2021051712122534000_59.9.1437.5 doi: 10.1371/journal.pone.0089741 – ident: 2021051712122534000_59.9.1437.20 doi: 10.1093/brain/awu290 – ident: 2021051712122534000_59.9.1437.46 doi: 10.1212/WNL.0b013e3182315259 – ident: 2021051712122534000_59.9.1437.39 doi: 10.1007/s00221-013-3621-2 – ident: 2021051712122534000_59.9.1437.30 doi: 10.1016/S1474-4422(10)70216-7 – ident: 2021051712122534000_59.9.1437.36 doi: 10.1007/s00415-011-6149-z – ident: 2021051712122534000_59.9.1437.43 doi: 10.1038/jcbfm.2015.173 |
| SSID | ssj0006888 ssj0062072 |
| Score | 2.5427806 |
| Snippet | Idiopathic REM sleep behavior disorder (iRBD) is considered a prodromal stage of Parkinson disease (PD) and other Lewy body disorders. Spatial covariance... |
| SourceID | unpaywall proquest pubmed crossref |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source |
| StartPage | 1437 |
| SubjectTerms | Brain diseases Brain stem Cerebellum Cognition Cognitive ability Correlation analysis Cortex (parietal) Covariance Glucose metabolism Hypometabolism Identification methods Lewy bodies Metabolic disorders Metabolism Movement disorders Neurodegenerative diseases Occipital lobe Parkinson's disease Patients Positron emission Positron emission tomography REM sleep Sleep Sleep disorders Somatosensory cortex Statistical analysis Temporal lobe Thalamus Tomography |
| Title | The Metabolic Pattern of Idiopathic REM Sleep Behavior Disorder Reflects Early-Stage Parkinson Disease |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/29476004 https://www.proquest.com/docview/2126563128 https://www.proquest.com/docview/2007982936 http://jnm.snmjournals.org/content/59/9/1437.full.pdf |
| UnpaywallVersion | publishedVersion |
| Volume | 59 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAFT databaseName: Open Access Digital Library customDbUrl: eissn: 2159-662X dateEnd: 20250505 omitProxy: true ssIdentifier: ssj0006888 issn: 0161-5505 databaseCode: KQ8 dateStart: 19640101 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries – providerCode: PRVBFR databaseName: Free Medical Journals customDbUrl: eissn: 2159-662X dateEnd: 20241105 omitProxy: true ssIdentifier: ssj0006888 issn: 0161-5505 databaseCode: DIK dateStart: 19640101 isFulltext: true titleUrlDefault: http://www.freemedicaljournals.com providerName: Flying Publisher – providerCode: PRVFQY databaseName: GFMER Free Medical Journals customDbUrl: eissn: 2159-662X dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0062072 issn: 0161-5505 databaseCode: GX1 dateStart: 0 isFulltext: true titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php providerName: Geneva Foundation for Medical Education and Research |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwEB612wPiAEW8gkplJE6gZLOO49jHCrVqi7YqhUXLKfKzKqTZVTcrBL-ecR4rqkqgnuM8Z5zvs2fmG4C3qZWFFzRkNxgds6CsLbizsbS504iwuaah3nl6xo9n7HSez7dg6FT4vb5OVvV1_x1XbSg_5GzjD3icy7EcI7wXSdiZTpbWb8MOz5GCj2BndnZ-8C00kkN4jjmn8y6CSSUv8KI4zW0IT-J6ECGL3sagO8TyITxY10v166eqqr_A5ugxfB1Kdrockx_JutGJ-X1XwfF-77ELj3r6SQ46f3kCW65-Ch59hUxdg_5QXRly3kpu1mThyYm9WrQ9iw25OJySz5VzS9JLKt6QQbmTXDgfdv9XpJVLjpHAXjoS6qnb0rIwLgSBnsHs6PDLh-O4778Qm6ygTYzUSmrlCz-ZWEm5tlxIJhQuAK1Jlct0WxfLqBfcqiLjmVLKO5cayTi1hcmew6he1O4lkFwYLRkLUjATpr2VKje5o16mkiqhJxGkg0VK04uThx4ZVYmLlGDEsjNi0CYvOyNG8G5zyrJT5vjX4L3BzOVglBJRG9lshggdwZvNYZxeIWaiardYr0KXzkIK5EQ8ghede2zuRiULYU0WwfuNv_z_UV7da_QejJqbtXuNzKfR-7D98ZPY7739Dzc4Bw4 |
| linkProvider | Unpaywall |
| linkToUnpaywall | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9NAEB6V9IA48BAvo4IWiRPIjrNer73HCrUqSKmqQlA4WfusCq4TNY4Q_Hpm_IhAlUA9e_2cWX_f7sx8A_AmdaoIJafsBmtiQcrapfQuVi73BhE2N5zqneen8mQhPi7z5R6MnQq_NVfJprkavuOmC-VTzjb-gKe5mqopwnuR0M50snbhDuzLHCn4BPYXp2eHX6mRHMJzLCVf9hFMrmSBF8Vp7ig8ietBhCz-NwbdIJb34O62WeufP3Rd_wE2xw_gy1iy0-eYfE-2rUnsr5sKjrd7j4dwf6Cf7LD3l0ew55vHENBX2Ny36A_1pWVnneRmw1aBfXCXq65nsWXnR3P2qfZ-zQZJxWs2Kneycx9o93_DOrnkGAnshWdUT92VltE4CgI9gcXx0ef3J_HQfyG2WcHbGKmVMjoUYTZzikvjZKlEqXEB6GyqfWa6uljBQymdLjKZaa2D96lVQnJX2OwpTJpV458Dy0trlBAkBTMTJjilc5t7HlSquC7NLIJ0tEhlB3Fy6pFRV7hIISNWvRFJm7zqjRjB290p616Z41-DD0YzV6NRKkRtZLMZInQEr3eHcXpRzEQ3frXdUJfOQpXIiWQEz3r32N2NK0FhTRHBu52__P9RXtxq9AFM2uutf4nMpzWvBj__DRKfBhk |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+Metabolic+Pattern+of+Idiopathic+REM+Sleep+Behavior+Disorder+Reflects+Early-Stage+Parkinson+Disease&rft.jtitle=Journal+of+Nuclear+Medicine&rft.au=Meles%2C+Sanne+K.&rft.au=Renken%2C+Remco+J.&rft.au=Janzen%2C+Annette&rft.au=Vadasz%2C+David&rft.date=2018-09-01&rft.issn=0161-5505&rft.eissn=2159-662X&rft.volume=59&rft.issue=9&rft.spage=1437&rft.epage=1444&rft_id=info:doi/10.2967%2Fjnumed.117.202242&rft.externalDBID=n%2Fa&rft.externalDocID=10_2967_jnumed_117_202242 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0161-5505&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0161-5505&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0161-5505&client=summon |